Literature DB >> 18984855

Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesis.

Karine Blouin1, Mélanie Nadeau, Jacques Mailloux, Marleen Daris, Stephane Lebel, Van Luu-The, André Tchernof.   

Abstract

The objective was to examine pathways of androgen metabolism in abdominal adipose tissue in women. Abdominal subcutaneous (SC) and omental (OM) adipose tissue samples were surgically obtained in women. Total RNA was isolated from whole adipose tissue samples and from primary preadipocyte cultures before and after induction of differentiation. Expression levels of several steroid-converting enzyme transcripts were examined by real-time RT-PCR. Androgen conversion rates were also measured. We found higher expression levels in SC compared with OM adipose tissue for type 1 3beta-hydroxysteroid dehydrogenase (3beta-HSD-1; P < 0.05), for aldo-keto reductase 1C3 (AKR1C3; P < 0.0001), for AKR1C2 (P < 0.0001), and for the androgen receptor (P < 0.0001). 17beta-HSD-2 mRNA levels were lower in SC adipose tissue (P < 0.05). Induction of adipocyte differentiation led to significantly increased expression levels in SC cultures for AKR1C3 (4.7-fold, P < 0.01), 11-cis-retinol dehydrogenase (6.9-fold, P < 0.02), AKR1C2 (5.6-fold, P < 0.004), P-450 aromatase (5.7-fold, P < 0.02), steroid sulfatase (3.1-fold, P < 0.02), estrogen receptor-beta (11.8-fold, P < 0.01), and the androgen receptor (4.0-fold, P < 0.0005). Generally similar but nonsignificant trends were obtained in OM cultures. DHT inactivation rates increased with differentiation, this effect being mediated by dexamethasone alone, through a glucocorticoid receptor-dependent mechanism. In conclusion, higher mRNA levels of enzymes synthesizing and inactivating androgens are found in differentiated adipocytes, consistent with higher androgen-processing rates in these cells. Glucocorticoid-induced androgen inactivation may locally modulate the exposure of adipose cells to active androgens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18984855     DOI: 10.1152/ajpendo.00039.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  22 in total

Review 1.  The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity.

Authors:  Frederick S Vom Saal; Susan C Nagel; Benjamin L Coe; Brittany M Angle; Julia A Taylor
Journal:  Mol Cell Endocrinol       Date:  2012-01-10       Impact factor: 4.102

2.  Androgens, body fat Distribution and Adipogenesis.

Authors:  Mouna Zerradi; Julie Dereumetz; Marie-Michèle Boulet; André Tchernof
Journal:  Curr Obes Rep       Date:  2014-12

3.  Feed-forward inhibition of androgen receptor activity by glucocorticoid action in human adipocytes.

Authors:  Sean M Hartig; Bin He; Justin Y Newberg; Scott A Ochsner; David S Loose; Rainer B Lanz; Neil J McKenna; Benjamin M Buehrer; Sean E McGuire; Marco Marcelli; Michael A Mancini
Journal:  Chem Biol       Date:  2012-09-21

4.  Gender-specific genetic associations of polymorphisms in ACE, AKR1C2, FTO and MMP2 with weight gain over a 10-year period.

Authors:  Freek G Bouwman; Jolanda M A Boer; Sandra Imholz; Ping Wang; W M Monique Verschuren; Martijn E T Dollé; Edwin C M Mariman
Journal:  Genes Nutr       Date:  2014-10-17       Impact factor: 5.523

5.  Age, Sex, and Depot-Specific Differences in Adipose-Tissue Estrogen Receptors in Individuals with Obesity.

Authors:  Jay W Porter; Jillian L Barnas; Rebecca Welly; Nicole Spencer; James Pitt; Victoria J Vieira-Potter; Jill A Kanaley
Journal:  Obesity (Silver Spring)       Date:  2020-07-31       Impact factor: 5.002

Review 6.  Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery.

Authors:  Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

7.  Affective Disorders, Bone Metabolism, and Osteoporosis.

Authors:  Briana Mezuk
Journal:  Clin Rev Bone Miner Metab       Date:  2008-12

8.  KLF15 Is a transcriptional regulator of the human 17beta-hydroxysteroid dehydrogenase type 5 gene. A potential link between regulation of testosterone production and fat stores in women.

Authors:  Xiaofei Du; Robert L Rosenfield; Kenan Qin
Journal:  J Clin Endocrinol Metab       Date:  2009-04-14       Impact factor: 5.958

9.  Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1.

Authors:  Jennifer C Carter; Frank C Church
Journal:  PPAR Res       Date:  2009-08-06       Impact factor: 4.964

10.  The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors.

Authors:  Lena Secky; Martin Svoboda; Lukas Klameth; Erika Bajna; Gerhard Hamilton; Robert Zeillinger; Walter Jäger; Theresia Thalhammer
Journal:  J Drug Deliv       Date:  2013-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.